Figure 6.
Plasma macrophage polarization markers in breast cancer patients. Plasma concentration of soluble CD163 protein (sCD163, A) and galectin 3 (Gal3, B) in healthy controls (n = 18), HR+ HER2+ BC (n = 12), HR+ HER2- BC (n = 16), and triple negative (TNBC, n = 19) breast cancer patients (C). Correlation plots of plasma sCD163 with tADA, ADA1, and ADA2 activities in TNBC (D). Results are shown as mean ± SEM, * p < 0.05 by one-way ANOVA followed by Holm-Sidak post hoc test (A), Kruskal-Wallis test followed by Dunn’s post hoc test (B) and as Pearson correlation coefficients with corresponded p-value (C).